Publications
5891 Results
- Journal / Conference
- J Clin Oncol 30:(suppl 4; abstr 391)
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
Patient-reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04
- Journal / Conference
- Investigational New Drugs 29(2):352-359;
- Year
- 2011
- Research Committee(s)
- Head and Neck
- PMID
- PMID19937365
- PMC
- PMC2892241
- Study Number(s)
- S0618
Phase II evaluation of eribulin mesylate (E7389 NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618
- Journal / Conference
- British Journal of Urology Internatonal, 108(5):693-699;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Do mixed histologic features affect survival benefit from neo-adjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer treated with radical cystectomy? A secondary analysis of Southwest Oncology Group-directed intergroup study (S8710) [PMID 21105991; PMC3117124
- Journal / Conference
- Journal of Clinical Oncology 29(8):1014-1021;
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S0012
SWOG 0012: a phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus G-CSF as neoadjuvant therapy for inflammatory and locally advanced breast cancer [PMID21220618; PMC3024910]
- Journal / Conference
- Cancer 117:4740-4746;
- Year
- 2011
- Research Committee(s)
- Melanoma
- PMID
- PMID21455999
- PMC
- PMC3129414
- Study Number(s)
- SWOG-9430
A phase II trial of complete resection for stage IV melanoma: results of Southwest Oncology Group (SWOG) clinical trial S9430
- Journal / Conference
- Urology 77(5):1172-1176; Epub 2011 Feb 21;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0032
Phase II evaluation of early oral estramustine, oral etoposide and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group (SWOG) S0032 [PMID21334731]
- Journal / Conference
- Journal of Clinical Oncology 29(15)2040-2045;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9921
Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study [PMID21502546; PMC3107759]
- Journal / Conference
- Journal of Thoracic Oncology, 6(1):115-120;
- Year
- 2011
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9308, SWOG-9509
Comparison of platinum based chemotherapy in patients older and younger than 70 years of age: an analysis of Southwest Oncology Group trials 9308 and 9509 [PMID21107287; PMC3075557]
- Journal / Conference
- Annals of Oncology, 22(12):2610-2615;
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0413
Southwest Oncology Group Study S0413: a phase II trial of GW572016 (lapatinib) as first line therapy in patients with advanced or metastatic gastric cancer [PMID21415234;PMC3221514]
- Journal / Conference
- Cancer Chemotherapy and Pharmacology 68(6):1595-602; 2011 May 20 [Epub ahead of print];
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0202